Shailendra S Gurav

InstitutionGoa University
AddressGoa
India
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 10 Covid-19 publications, with a maximum of 3 publications in June 2020
    All Publications
    Bar chart showing 10 publications over 2 distinct years, with a maximum of 6 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Santhi VP, Masilamani P, Sriramavaratharajan V, Murugan R, Gurav SS, Sarasu VP, Parthiban S, Ayyanar M. Therapeutic potential of phytoconstituents of edible fruits in combating emerging viral infections. J Food Biochem. 2021 Jul 08; e13851. PMID: 34236082.
      Citations: 2     Fields:    
    2. Khanal P, Duyu T, Patil BM, Dey YN, Pasha I, Kavalapure RS, Chand S, Gurav S. Screening of JAK-STAT modulators from the antiviral plants of Indian traditional system of medicine with the potential to inhibit 2019 novel coronavirus using network pharmacology. 3 Biotech. 2021 Mar; 11(3):119. PMID: 33585152.
      Citations:    
    3. Chikhale R, Sinha SK, Wanjari M, Gurav NS, Ayyanar M, Prasad S, Khanal P, Dey YN, Patil RB, Gurav SS. Computational assessment of saikosaponins as adjuvant treatment for COVID-19: molecular docking, dynamics, and network pharmacology analysis. Mol Divers. 2021 Aug; 25(3):1889-1904. PMID: 33492566.
      Citations: 6     Fields:    Translation:HumansCells
    4. Khanal P, Chikhale R, Dey YN, Pasha I, Chand S, Gurav N, Ayyanar M, Patil BM, Gurav S. Withanolides from Withania somnifera as an immunity booster and their therapeutic options against COVID-19. J Biomol Struct Dyn. 2021 Jan 18; 1-14. PMID: 33459174.
      Citations: 6     Fields:    
    5. Patil R, Chikhale R, Khanal P, Gurav N, Ayyanar M, Sinha S, Prasad S, Dey YN, Wanjari M, Gurav SS. Computational and network pharmacology analysis of bioflavonoids as possible natural antiviral compounds in COVID-19. Inform Med Unlocked. 2021; 22:100504. PMID: 33363251.
      Citations: 7     
    6. Khanal P, Duyu T, Patil BM, Dey YN, Pasha I, Wanjari M, Gurav SS, Maity A. Network pharmacology of AYUSH recommended immune-boosting medicinal plants against COVID-19. J Ayurveda Integr Med. 2022 Jan-Mar; 13(1):100374. PMID: 33250601.
      Citations: 8     
    7. Chikhale RV, Sinha SK, Patil RB, Prasad SK, Shakya A, Gurav N, Prasad R, Dhaswadikar SR, Wanjari M, Gurav SS. In-silico investigation of phytochemicals from Asparagus racemosus as plausible antiviral agent in COVID-19. J Biomol Struct Dyn. 2021 09; 39(14):5033-5047. PMID: 32579064.
      Citations: 21     Fields:    Translation:HumansCells
    8. Chikhale RV, Gurav SS, Patil RB, Sinha SK, Prasad SK, Shakya A, Shrivastava SK, Gurav NS, Prasad RS. Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach. J Biomol Struct Dyn. 2021 Aug; 39(12):4510-4521. PMID: 32568012.
      Citations: 30     Fields:    Translation:HumansAnimalsCells
    9. Sinha SK, Prasad SK, Islam MA, Gurav SS, Patil RB, AlFaris NA, Aldayel TS, AlKehayez NM, Wabaidur SM, Shakya A. Identification of bioactive compounds from Glycyrrhiza glabra as possible inhibitor of SARS-CoV-2 spike glycoprotein and non-structural protein-15: a pharmacoinformatics study. J Biomol Struct Dyn. 2021 08; 39(13):4686-4700. PMID: 32552462.
      Citations: 29     Fields:    Translation:HumansAnimalsCells
    10. Sinha SK, Shakya A, Prasad SK, Singh S, Gurav NS, Prasad RS, Gurav SS. An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets. J Biomol Struct Dyn. 2021 Jun; 39(9):3244-3255. PMID: 32345124.
      Citations: 28     Fields:    Translation:HumansCells